Pharma Firms Welcome 'Pragmatic' EU Reforms But Concerns Persist

 
• By Kevin Grogan

The European parliament has voted for legislation it says will lead to fairer, more accessible healthcare. The continent's drugmakers are still not wholly convinced.

EFPIA leadership
David Loew, Nathalie Moll, Lars Fruergaard Jørgensen (Novo Nordisk CEO and EFPIA president) and Stefan Oelrich (head of pharma at Bayer and EFPIA first vice president) • Source: EFPIA

More from Drug Pricing

More from Scrip